Respiratory Function Assessment in Patients With Atrial Fibrillation: A Needed Extension of Combined Comorbidity Management?

Can J Cardiol. 2023 May;39(5):623-624. doi: 10.1016/j.cjca.2023.02.006. Epub 2023 Feb 11.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anticoagulants
  • Atrial Fibrillation* / complications
  • Atrial Fibrillation* / epidemiology
  • Atrial Fibrillation* / therapy
  • Comorbidity
  • Humans
  • Risk Factors

Substances

  • Anticoagulants